Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease

被引：0
|
作者：
Bloom, JM [1 ]
机构：
[1] Cent Coast Primary Care, San Luis Obispo, CA 93401 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 341卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1854 / 1854
页数：1
相关论文
共 50 条
  • [41] Trials of lipid-lowering therapy in secondary prevention of coronary heart disease
    Olsson, AG
    Pedersen, T
    Bergdahl, B
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 369 - 373
  • [42] Regression of coronary atherosclerosis in patients with coronary artery disease and normal cholesterol, less than 180 mg/dl by aggressive lipid-lowering therapy with pravastatin.
    Ueno, T
    Ikeda, H
    Kai, H
    Murohara, T
    Hashino, T
    Haramaki, N
    Eguchi, H
    Kato, A
    Takajo, Y
    Onitsuka, I
    CIRCULATION, 1998, 98 (17) : 534 - 534
  • [43] Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy
    Yamamoto, Hiroyuki
    Shinke, Toshiro
    Otake, Hiromasa
    Kawamori, Hiroyuki
    Toba, Takayoshi
    Kuroda, Masaru
    Hirota, Yushi
    Sakaguchi, Kazuhiko
    Ogawa, Wataru
    Hirata, Ken-ichi
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (06) : 1015 - 1024
  • [44] Lipid-lowering treatment in peripheral artery disease
    Katsiki, Niki
    Giannoukas, Athanasios D.
    Athyros, Vasilios G.
    Mikhailidis, Dimitri P.
    CURRENT OPINION IN PHARMACOLOGY, 2018, 39 : 19 - 26
  • [45] Lipid-lowering treatment in coronary artery disease: a survey in an ambulatory outpatient clinic
    Harder, S
    Mohr, O
    Klepzig, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (12) : 534 - 538
  • [46] Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease
    Joel Hay
    Winnie M. Yu
    Talat Ashraf
    PharmacoEconomics, 1999, 15 : 47 - 74
  • [47] Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease
    Hay, JW
    Yu, WM
    Ashraf, T
    PHARMACOECONOMICS, 1999, 15 (01) : 47 - 74
  • [48] LIPID LOWERING THERAPY AND THE PROGRESSION OF CORONARY-ARTERY DISEASE
    NASH, DT
    GENSINI, GG
    ESENCE, P
    CIRCULATION, 1980, 62 (04) : 122 - 122
  • [49] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
  • [50] Lipid-lowering therapy in chronic kidney disease
    Fernández-Vega, F
    NEFROLOGIA, 2004, 24 (06): : 113 - 126
12345